The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
ALEXANDRIA, Va. - Today the American Society of Clinical Oncology (ASCO) issued a provisional clinical opinion (PCO) recommending that all patients with metastatic non-small cell lung cancer (NSCLC) be offered palliative care along with standard cancer therapy, beginning at the time of diagnosis.
ALEXANDRIA, Va. – Eight noteworthy abstracts from the 2012 Genitourinary Cancers Symposium will focus on the late effects of prostate cancer treatment, as well as new treatments for prostate and kidney cancers. The findings will be presented during this year’s Symposium, which takes place February 2-4 in San Francisco.
ALEXANDRIA, Va. – Research on promising new therapies and data on the relative benefits of established treatments for prostate cancer were released today, in advance of the fourth annual Genitourinary Cancers Symposium, being held February 2-4, 2012, at the San Francisco Marriott Marquis in San Francisco, Calif.
Cancer patients continue to face shortages of critical therapies for which there are often no acceptable substitutions. Last year, the medical community experienced a record number of shortages and the situation is expected to worsen without action from Congress. The American Society of Clinical Oncology (ASCO) is pleased that U.S. Representatives John Carney [D-DE] and Larry Bucshon [R-IN] have introduced legislation that will begin to address this crisis.
ALEXANDRIA, Va. – Co-sponsors of the 2012 Gastrointestinal Cancers Symposium today announced six additional important studies on the surveillance, detection and treatment of pancreatic, gastric, colorectal and esophageal cancers. The findings will be presented during this year’s Symposium, which takes place January 19-21 in San Francisco.
ALEXANDRIA, Va. - Five key studies from the 2012 Genitourinary Cancers Symposium will be featured in an embargoed presscast for reporters on Tuesday, January 31, 2012, from 12:00-1:30 PM (EST). Highlighted studies will focus on the latest improvements being made in the detection and treatment of several genitourinary cancers. The presscast will be moderated by Nicholas Vogelzang, MD, a member of the 2012 Genitourinary Cancers Symposium News Planning Team and Chair of the ASCO Cancer Communications Committee.
ALEXANDRIA, Va. – New research into the treatment, prognosis and early detection of gastrointestinal cancers was released today in advance of the ninth annual Gastrointestinal Cancers Symposium being held January 19-21, 2012, at The Moscone West Building in San Francisco, Calif.
ALEXANDRIA, Va. – Four noteworthy studies from the 2012 Gastrointestinal Cancers Symposium will be featured in an embargoed presscast for reporters on Tuesday, January 17, 2012, from 12:00-1:30 PM (EST).
ASCO thanks those in the U.S. Senate who today reaffirmed the value of cancer research by honoring the National Cancer Act of 1971. Forty years after that landmark legislation, ASCO urges members of both houses of Congress to help sustain the nation's commitment to conquer cancer through continued research.
December marks the 40th anniversary of the National Cancer Act, landmark legislation that led to major U.S. investments in cancer research that have spurred significant increases in survival and a revolution in our understanding of cancer. This week, the U.S. Senate will introduce a resolution that reaffirms the national commitment to understanding and controlling cancer.
